Trade PALI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Palisade Bio, Inc. (PALI) is trading at US$1.54, up 6.21% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$365.97M. Over the past 52 weeks, PALI has traded between US$1.32 and US$2.86. On Syfe you can trade PALI with $0 commission and add it to your watchlist.
| Previous close | US$1.45 |
|---|---|
| Market cap | US$365.97M |
| 52-week range | US$1.32 – US$2.86 |
| Volume | 1.84M |
| Exchange | US |
Palisade Bio, Inc.
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.
Year: 2021
--Oppenheimer Initiates Coverage on Palisade Bio With Outperform Rating, $8 Price Target
Jul 23, 11:41 AM · MT Newswires
Palisade Bio Gets FDA IND Clearance for Phase 2 PALI-2108 UC Study
Jun 29, 1:03 PM · MT Newswires
Palisade Bio, Inc. (PALI) stock is trading at US$1.54, +6.21% from the previous close of US$1.45.
The market cap for Palisade Bio, Inc. (PALI) stock is approximately US$365.97M.
The 52-week high for Palisade Bio, Inc. (PALI) stock is US$2.86.
The 52-week low for Palisade Bio, Inc. (PALI) stock is US$1.32.
Palisade Bio, Inc. (PALI) does not currently pay a dividend.
Stay on top of PALI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
